Cargando…
Characterization of Tigecycline-Heteroresistant Klebsiella pneumoniae Clinical Isolates From a Chinese Tertiary Care Teaching Hospital
Tigecycline has been used as one of the therapeutic choices for the treatment of infections caused by multidrug-resistant Klebsiella pneumoniae. However, the emergence of tigecycline heteroresistance has led to great challenges in treating these infections. The purpose of this study was to investiga...
Autores principales: | Zhang, Qiaoyu, Lin, Liping, Pan, Yuhong, Chen, Jiansen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369762/ https://www.ncbi.nlm.nih.gov/pubmed/34413834 http://dx.doi.org/10.3389/fmicb.2021.671153 |
Ejemplares similares
-
Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae
por: Tian, Yuan, et al.
Publicado: (2021) -
Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
por: Zhang, Feiyang, et al.
Publicado: (2021) -
Genomic characterization of tigecycline-resistant Escherichia coli and Klebsiella pneumoniae isolates from hospital sewage
por: Li, Ying, et al.
Publicado: (2023) -
Antibiotic Heteroresistance in Klebsiella pneumoniae
por: Stojowska-Swędrzyńska, Karolina, et al.
Publicado: (2021) -
Characterization of Tigecycline Resistance Among Tigecycline Non-susceptible Klebsiella pneumoniae Isolates From Humans, Food-Producing Animals, and in vitro Selection Assay
por: Moghimi, Mohaddeseh, et al.
Publicado: (2021)